<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20190920044826N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-01-18</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>Evaluation of the effect of tecartherapy on hamstring muscles shortness</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the short-term effect of therapeutic ultrasound and TECAR therapy on hamstring muscle flexibility in healthy athlete men with hamstring shortness: A randomized controlled trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-06-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/42289</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Each individual were included in one of the TECAR therapy or ultrasound therapy or static stretching groups by  simple randomization method (using the dice throw method). By throwing dice the numbers 1 and 2 fall into group 1 (TECAR therapy), and the numbers 3 and 4 fall into group 2 (ultrasound) and the numbers 5 and 6 fall into group 3 (static stretch), Blinding description: A physiotherapist who performs pre-treatment evaluations, at the end of the first session, and at the end of the third session will not be aware of the type of treatment's group. treatment will be performed by the second physiotherapist.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Shortness of Hamstring Muscle.</hc_freetext>
      <i_freetext>Intervention 1: Intervention Group 1:Tecartherapy with Static stretching:                        This group will recieve capacitive Tecartherapy for 15 minutes at the frequency of 0.5 MHz  and at the intensity of 140 Hz before the static stretch , with the passive electrode plate size 230×170 mm, And the active electrode is 5 cm2 on the hamstring muscle group for 3 sessions in a week every other day.(Details of stretching are provided in control group ). Intervention 2: Intervention group 2: Ultrasound therapy with static stretching: This group will receive continuous ultrasound therapy at a frequency of 1 MHz and at the intensity of 2 W/cm2 and at a speed of 2 cm / s before static stretching (details of stretching in the control group) for 15 minutes on the hamstring muscle group in relax situation for 3 sessions in a week every other day. For this reason, the patient is placed on a prone position.(Details of stretching are provided in control group). Intervention 3: Control group:static stretch:                                                                         The individual is in an supine position and the hip and knee joints are stretched at 90 degrees flexion. To prevent posterior pelvic tilt and lumbar flexion، pelvic is fixed. For this reason, the opposite leg is pushed down by the examiner. The examiner gently lifts the person's knees to straighten the knee to reach the end point of the range of motion and feel stretched under his arm. Stretching is given for 30 seconds, very slowly, gently and gradually to  prevent stimulation of  stretch reflex and increase muscle tone. After each stretch, rest for 5 seconds and repeat four times to achieve a total of two minutes.this process were performed for 3 sessions in a week every other day.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Only part of the data, such as information about the main outcome, can be shared.

When:
One year after the results were published

To whom:
Available to all physiotherapists.

Conditions:
No more conditions.

Where to obtain:
pooryamohamadi1372@gmail.com Email this address

How to obtain:
It takes about 3 months to send the data back to the applicant

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Pouria Mohamadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No.55, Shahid Parsi Ave., Shouhadaye Fardis Blvd., Fardis Town</address>
        <city>Karaj</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3175998467</zip>
        <telephone>+98 26 3650 3372</telephone>
        <email>pooryamohamadi1372@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Pouria Mohamadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No.55, Shahid Parsi Ave., Shouhadaye Fardis Blvd., Fardis Town</address>
        <city>Karaj</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3175998467</zip>
        <telephone>+98 26 3650 3372</telephone>
        <email>pooryamohamadi1372@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>20-30 years old
shortness of hamstring muscle based on 90-90 test.
Men must do exercise 3 times a week and 2 hours in each session.</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>30 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria>Unwillingness to participate in the study
contraindication of the TECAR intervention .
history of orthopedic and neurological injuries in the lower extremities in last 6 month.
Acute low back pain and low back problems</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention Group 1:Tecartherapy with Static stretching:                        This group will recieve capacitive Tecartherapy for 15 minutes at the frequency of 0.5 MHz  and at the intensity of 140 Hz before the static stretch , with the passive electrode plate size 230×170 mm, And the active electrode is 5 cm2 on the hamstring muscle group for 3 sessions in a week every other day.(Details of stretching are provided in control group )</i_keyword>
      <i_keyword>Intervention group 2: Ultrasound therapy with static stretching: This group will receive continuous ultrasound therapy at a frequency of 1 MHz and at the intensity of 2 W/cm2 and at a speed of 2 cm / s before static stretching (details of stretching in the control group) for 15 minutes on the hamstring muscle group in relax situation for 3 sessions in a week every other day. For this reason, the patient is placed on a prone position.(Details of stretching are provided in control group)</i_keyword>
      <i_keyword>Control group:static stretch:                                                                         The individual is in an supine position and the hip and knee joints are stretched at 90 degrees flexion. To prevent posterior pelvic tilt and lumbar flexion، pelvic is fixed. For this reason, the opposite leg is pushed down by the examiner. The examiner gently lifts the person's knees to straighten the knee to reach the end point of the range of motion and feel stretched under his arm. Stretching is given for 30 seconds, very slowly, gently and gradually to  prevent stimulation of  stretch reflex and increase muscle tone. After each stretch, rest for 5 seconds and repeat four times to achieve a total of two minutes.this process were performed for 3 sessions in a week every other day.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Flexibility of Distal Head of Hamstring Muscle. Timepoint: Before treatment ، Immediately after the first session ، Immediately after the third session (Intervention sessions take place 3 days in a week). Method of measurement: Passive 90-90 test ، Active 90-90 test.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Flexibility of Proximal Head of Hamstring. Timepoint: Before treatment ، Immediately after the first session ، Immediately after the third session (Intervention sessions take place 3 days in a week). Method of measurement: Sit and Reach Test.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-06-25</approval_date>
        <contact_name>Ethics committee of School of Nursing and Midwifery &amp; Rehabilitation - Tehran University of Medical</contact_name>
        <contact_address>Nosrat st. Tohid sq. Tehran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
